Hospital
Lakewood Ranch Medical Center
Lakewood Ranch Medical Center was paid $3.90M by Medicaid between Jan 2018 and Nov 2024, across 90 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoLAKEWOOD RANCH MEDICAL CENTER
BRADENTON, FL 34202
BRADENTON, FL 34202
33aNPI1730179714assigned 10/21/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.90M
24GClaims131,441
24DCodes billed90
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#92 of 163
Median peer was paid$4.77M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,347 | $106K | |
| 2019 | 25,297 | $444K | |
| 2020 | 23,044 | $425K | |
| 2021 | 28,366 | $713K | |
| 2022 | 31,256 | $1.27M | |
| 2023 | 13,589 | $711K | |
| 2024incomplete | 3,542 | $233K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 11,073 | 10,177 | $971K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 10,355 | 8,952 | $868K |
| 36415 | Collection of venous blood by venipuncture | 12% | 10,484 | 8,224 | $479K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 6,029 | 5,145 | $355K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.3% | 2,554 | 2,378 | $245K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.6% | 691 | 599 | $180K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.3% | 788 | 700 | $167K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.7% | 1,110 | 899 | $145K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.7% | 2,999 | 2,576 | $143K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,748 | 1,604 | $26K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 979 | 865 | $24K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 931 | 787 | $24K |
78 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,558 | $23K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 353 | $23K |
| 87070 | <1% | 904 | $22K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,626 | $20K |
| 80053 | Comprehensive metabolic panel | <1% | 6,780 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,675 | $12K |
| 81003 | <1% | 1,517 | $12K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 274 | $12K |
| G0378 | Hospital observation service, per hour | <1% | 622 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,762 | $11K |
| 81001 | <1% | 5,052 | $10K | |
| 71045 | Radiologic examination, chest; single view | <1% | 2,379 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,587 | $8K |
| 81025 | <1% | 3,587 | $8K | |
| 87077 | <1% | 789 | $8K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,211 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,652 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 695 | $6K |
| 87420 | <1% | 161 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 26 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,962 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 224 | $5K |
| 73610 | <1% | 85 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 194 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 130 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,832 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 339 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,679 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,265 | $1K |
| 73564 | <1% | 57 | $1K | |
| 85610 | <1% | 1,491 | $1K | |
| 73630 | <1% | 164 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 51 | $1K |
| 85730 | <1% | 1,113 | $1K | |
| A9270 | Non-covered item or service | <1% | 1,358 | $1K |
| 73110 | <1% | 48 | $940.09 | |
| 87430 | <1% | 731 | $872.27 | |
| 84484 | <1% | 1,979 | $832.76 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 291 | $704.33 |
| 83690 | <1% | 3,078 | $683.93 | |
| 83735 | <1% | 1,199 | $676.66 | |
| 87186 | <1% | 797 | $504.85 | |
| 76801 | <1% | 82 | $404.57 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 578 | $367.73 |
| 84702 | <1% | 803 | $361.90 | |
| 86900 | <1% | 387 | $326.30 | |
| 73130 | <1% | 59 | $323.76 | |
| 85027 | <1% | 339 | $276.90 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 458 | $265.58 |
| 82948 | <1% | 48 | $231.84 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 338 | $209.04 |
| 86901 | <1% | 387 | $207.81 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 357 | $181.36 |
| J2704 | Injection, propofol, 10 mg | <1% | 348 | $171.51 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,148 | $164.33 |
| 87040 | <1% | 126 | $159.46 | |
| 74018 | <1% | 13 | $145.84 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 948 | $113.90 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 751 | $105.85 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 40 | $69.59 |
| 96376 | <1% | 37 | $40.69 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,724 | $26.83 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 500 | $25.87 |
| 80076 | <1% | 139 | $23.14 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 127 | $18.36 |
| 83880 | <1% | 123 | $16.98 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 117 | $0.00 |
| 86850 | 0% | 16 | $0.00 | |
| 83605 | 0% | 15 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 29 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 46 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 44 | $0.00 |
| 82962 | 0% | 21 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 0% | 13 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 222 | $0.00 |
| 0353U | 0% | 13 | $0.00 | |
| 82140 | 0% | 15 | $0.00 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (CFO, SENIOR VP)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.